Those developing the vaccine likely studied which viral epitopes (structural elements of the virus, consisting of multiple amino acids in a specific folded conformation) were recognized by antibodies from previously infected individuals. The frequency with which antibodies from different individuals are specific to any given epitope can indicate which epitopes might be best used in a vaccine.